2-[4-[2-[3-(5-aminopyrazin-2-yl)-6-cyclobutyl-2-fluorophenoxy]ethyl]phenyl]-2-hydroxy-1-phenylethanone
C30H28FN3O3 — CID 118590991
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[4-[2-[3-(5-aminopyrazin-2-yl)-6-cyclobutyl-2-fluorophenoxy]ethyl]phenyl]-2-hydroxy-1-phenylethanone
2-[4-[2-[3-(5-aminopyrazin-2-yl)-6-cyclobutyl-2-fluorophenoxy]ethyl]phenyl]-2-hydroxy-1-phenylethanone (PubChem CID 118590991) has the molecular formula C30H28FN3O3 and a molecular weight of 497.57 g/mol. Its IUPAC name is 2-[4-[2-[3-(5-aminopyrazin-2-yl)-6-cyclobutyl-2-fluorophenoxy]ethyl]phenyl]-2-hydroxy-1-phenylethanone.
Molecular Properties
| Compound Name | 2-[4-[2-[3-(5-aminopyrazin-2-yl)-6-cyclobutyl-2-fluorophenoxy]ethyl]phenyl]-2-hydroxy-1-phenylethanone |
|---|---|
| PubChem CID | 118590991 |
| Molecular Formula | C30H28FN3O3 |
| Molecular Weight | 497.57 g/mol |
| Exact Mass | 497.21 |
| IUPAC Name | 2-[4-[2-[3-(5-aminopyrazin-2-yl)-6-cyclobutyl-2-fluorophenoxy]ethyl]phenyl]-2-hydroxy-1-phenylethanone |
| SMILES | Nc1cnc(-c2ccc(C3CCC3)c(OCCc3ccc(C(O)C(=O)c4ccccc4)cc3)c2F)cn1 |
| InChI | InChI=1S/C30H28FN3O3/c31-27-24(25-17-34-26(32)18-33-25)14-13-23(20-7-4-8-20)30(27)37-16-15-19-9-11-22(12-10-19)29(36)28(35)21-5-2-1-3-6-21/h1-3,5-6,9-14,17-18,20,29,36H,4,7-8,15-16H2,(H2,32,34) |
| InChIKey | SJNADIWMTZQZJS-UHFFFAOYSA-N |
| XLogP | 5.67 |
| TPSA | 98.33 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 37 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 497.57 |
| LogP ≤ 5 | 5.67 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118590991 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.